Christian Dolder

Summary

Affiliation: Wingate University
Country: USA

Publications

  1. doi request reprint The efficacy and safety of newer anticonvulsants in patients with dementia
    Christian R Dolder
    Wingate University School of Pharmacy, Wingate, NC 28174, USA
    Drugs Aging 29:627-37. 2012
  2. ncbi request reprint The effects of mirtazapine on sleep in patients with major depressive disorder
    Christian R Dolder
    Wingate University School of Pharmacy, NC 28174, USA
    Ann Clin Psychiatry 24:215-24. 2012
  3. doi request reprint Valproic acid in dementia: does an optimal dose exist?
    Christian R Dolder
    School of Pharmacy, Wingate University, Wingate, NC 28174, USA
    J Pharm Pract 25:142-50. 2012
  4. ncbi request reprint Cardiovascular medication prescribing in older adults with psychiatric disorders
    Christian R Dolder
    Wingate University School of Pharmacy, Wingate, NC 28174, USA
    Consult Pharm 22:660-8. 2007
  5. doi request reprint Paliperidone for schizophrenia
    Christian Dolder
    School of Pharmacy, Wingate University, Wingate, NC 28174, USA
    Am J Health Syst Pharm 65:403-13. 2008
  6. doi request reprint Hypnosedative-induced complex behaviours : incidence, mechanisms and management
    Christian R Dolder
    Wingate University School of Pharmacy, Wingate, North Carolina 28174, USA
    CNS Drugs 22:1021-36. 2008
  7. doi request reprint Agomelatine treatment of major depressive disorder
    Christian R Dolder
    School of Pharmacy, Wingate University, Wingate, NC 28174, USA
    Ann Pharmacother 42:1822-31. 2008
  8. doi request reprint Memantine dosing in patients with dementia
    Christian Dolder
    Wingate University School of Pharmacy, Wingate, NC 28174, USA
    Am J Geriatr Psychiatry 17:170-3. 2009
  9. doi request reprint Low-dose divalproex in agitated patients with Alzheimer's disease
    Christian Dolder
    Wingate University School of Pharmacy, Campus Box 3087, Wingate, NC 28174, USA
    J Psychiatr Pract 16:63-7. 2010
  10. doi request reprint Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients
    Christian Dolder
    Wingate University School of Pharmacy, North Carolina 28174, USA
    Drugs Aging 27:625-40. 2010

Detail Information

Publications33

  1. doi request reprint The efficacy and safety of newer anticonvulsants in patients with dementia
    Christian R Dolder
    Wingate University School of Pharmacy, Wingate, NC 28174, USA
    Drugs Aging 29:627-37. 2012
    ..e. somnolence, dizziness, hyponatraemia, weight loss)...
  2. ncbi request reprint The effects of mirtazapine on sleep in patients with major depressive disorder
    Christian R Dolder
    Wingate University School of Pharmacy, NC 28174, USA
    Ann Clin Psychiatry 24:215-24. 2012
    ..The purpose of this article is to provide clinicians with a detailed review of mirtazapine's sleep effects in patients with MDD...
  3. doi request reprint Valproic acid in dementia: does an optimal dose exist?
    Christian R Dolder
    School of Pharmacy, Wingate University, Wingate, NC 28174, USA
    J Pharm Pract 25:142-50. 2012
    ..Overall, valproic acid appears to have limited efficacy as monotherapy in many patients with dementia. Its optimal role may be in combination with other psychotropics as a treatment of agitation associated with dementia...
  4. ncbi request reprint Cardiovascular medication prescribing in older adults with psychiatric disorders
    Christian R Dolder
    Wingate University School of Pharmacy, Wingate, NC 28174, USA
    Consult Pharm 22:660-8. 2007
    ..Secondary aims included examining: 1) if differences in CV medication prescribing existed between admission and discharge and 2) if differences in CV medication prescribing existed between patients with and without dementia...
  5. doi request reprint Paliperidone for schizophrenia
    Christian Dolder
    School of Pharmacy, Wingate University, Wingate, NC 28174, USA
    Am J Health Syst Pharm 65:403-13. 2008
    ..The efficacy, safety, pharmacology, pharmacokinetics, drug-drug interactions, and administration of paliperidone for schizophrenia are reviewed...
  6. doi request reprint Hypnosedative-induced complex behaviours : incidence, mechanisms and management
    Christian R Dolder
    Wingate University School of Pharmacy, Wingate, North Carolina 28174, USA
    CNS Drugs 22:1021-36. 2008
    ....
  7. doi request reprint Agomelatine treatment of major depressive disorder
    Christian R Dolder
    School of Pharmacy, Wingate University, Wingate, NC 28174, USA
    Ann Pharmacother 42:1822-31. 2008
    ..To review the efficacy, safety, pharmacologic, and pharmacokinetic data of agomelatine to better understand its potential role in the treatment of patients with major depressive disorder...
  8. doi request reprint Memantine dosing in patients with dementia
    Christian Dolder
    Wingate University School of Pharmacy, Wingate, NC 28174, USA
    Am J Geriatr Psychiatry 17:170-3. 2009
    ..To examine the dosing of memantine in patients with dementia admitted to an inpatient geriatric psychiatry ward and review the published literature regarding the pharmacologic and clinical need to dose adjust memantine...
  9. doi request reprint Low-dose divalproex in agitated patients with Alzheimer's disease
    Christian Dolder
    Wingate University School of Pharmacy, Campus Box 3087, Wingate, NC 28174, USA
    J Psychiatr Pract 16:63-7. 2010
    ..Adverse events occurred in 25% of patients. This case series suggests that low-dose divalproex may offer behavioral improvement and a reduced risk of side effects for some patients with agitation in Alzheimer's disease...
  10. doi request reprint Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients
    Christian Dolder
    Wingate University School of Pharmacy, North Carolina 28174, USA
    Drugs Aging 27:625-40. 2010
    ..Conclusions regarding desvenlafaxine cannot be made at this time because of a lack of geriatric-specific data...
  11. doi request reprint Use of psychostimulants in patients with dementia
    Christian R Dolder
    Wingate University, NC, USA
    Ann Pharmacother 44:1624-32. 2010
    ..To review the efficacy and safety of psychostimulants for negative behavioral symptoms (ie, apathy, excessive daytime sedation) and cognition in patients with dementia...
  12. doi request reprint Quetiapine for sleep in patients with dementia
    Christian R Dolder
    Wingate University School of Pharmacy, Wingate, North Carolina 28174, USA
    Consult Pharm 25:676-9. 2010
    ..to examine the use of quetiapine for sleep in patients with dementia admitted to a geriatric psychiatry ward...
  13. doi request reprint Antipsychotic polypharmacy among patients admitted to a geriatric psychiatry unit
    Christian R Dolder
    Wingate University School of Pharmacy, Wingate, NC 28174, USA
    J Psychiatr Pract 17:368-74. 2011
    ....
  14. ncbi request reprint Use of non-benzodiazepine hypnotics in the elderly: are all agents the same?
    Christian Dolder
    Wingate University School of Pharmacy, Wingate, North Carolina 28174, USA
    CNS Drugs 21:389-405. 2007
    ..While some actual and potential differences exist among these medications, more comparative trials are needed...
  15. ncbi request reprint Dutasteride: a dual 5-alpha reductase inhibitor for the treatment of symptomatic benign prostatic hyperplasia
    Christian R Dolder
    School of Pharmacy, Wingate University, Wingate, NC Pharmacist, NorthEast Medical Center, Concord, NC 28174, USA
    Ann Pharmacother 40:658-65. 2006
    ..To review the pharmacology, pharmacokinetics, efficacy, safety, drug interactions, and dosing recommendations of dutasteride, a 5-alpha reductase inhibitor for benign prostatic hyperplasia (BPH)...
  16. doi request reprint Fesoterodine for the treatment of overactive bladder
    Maria Tzefos
    School of Pharmacy, Wingate University, Wingate, NC 28174, USA
    Ann Pharmacother 43:1992-2000. 2009
    ..To review pharmacologic, pharmacokinetic, efficacy, and safety data for fesoterodine and determine its role in the treatment of overactive bladder...
  17. doi request reprint Certolizumab pegol: a TNF-{alpha} antagonist for the treatment of moderate-to-severe Crohn's disease
    Lisa S Smith
    School of Pharmacy, Wingate University, Wingate, NC, USA
    Ann Pharmacother 44:333-42. 2010
    ..To review certolizumab pegol for the treatment of moderate-to-severe Crohn's disease (CD)...
  18. ncbi request reprint Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors
    Michael H Nelson
    School of Pharmacy, Wingate University, Wingate, NC 28174 0159, USA
    Ann Pharmacother 40:261-9. 2006
    ..To review the pharmacology, pharmacokinetics, clinical trials, adverse effects, and drug interactions of lapatinib...
  19. ncbi request reprint A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia
    Haya Ascher-Svanum
    Eli Lilly and Co, Lilly Corporate Center, Indianapolis, IN 46285, USA
    J Clin Psychiatry 67:1114-23. 2006
    ..This study aimed to prospectively identify the best single predictor and the best set of predictors of risk for nonadherence with anti-psychotic medication in the treatment of patients with schizophrenia...
  20. ncbi request reprint Atypical antipsychotics in elderly patients with dementia or schizophrenia: review of recent literature
    Dilip V Jeste
    Department of Psychiatry, University of California San Diego, and Veterans Affairs San Diego Healthcare System 116A 1, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
    Harv Rev Psychiatry 13:340-51. 2005
    ..Clinical judgment, caution, and consent should be the watchwords in this area of psychopharmacology...
  21. ncbi request reprint Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience
    Sandra S Kindermann
    University of California, San Diego, California, USA
    Drugs Aging 19:257-76. 2002
    ..Additional large-scale, well-controlled studies are needed before conclusive statements regarding the value of treatment of psychosis and agitation with atypical antipsychotics and non-antipsychotic agents can be made...
  22. ncbi request reprint Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature
    Jonathan P Lacro
    Department of Psychiatry, University of California, and Veterans Affairs San Diego Healthcare System, 92161, USA
    J Clin Psychiatry 63:892-909. 2002
    ..This article reviews recent literature on the prevalence of and risk factors for medication nonadherence in patients with schizophrenia...
  23. ncbi request reprint Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients
    Christian R Dolder
    Department of Psychiatry, University of California San Diego, and Veterans Affairs San Diego Healthcare Sysytem, San Diego, California 92121, USA
    Biol Psychiatry 53:1142-5. 2003
    ..Among patients at a very high risk for worsening tardive dyskinesia, the use of atypical antipsychotics was associated with a significantly lower risk of developing definitive tardive dyskinesia compared with conventional antipsychotics...
  24. ncbi request reprint Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia
    Shafali D Jeste
    Children s Hospital Boston, Boston, MA 02115, USA
    Schizophr Res 63:49-58. 2003
    ....
  25. ncbi request reprint Interventions to improve antipsychotic medication adherence: review of recent literature
    Christian R Dolder
    Department of Psychiatry, University of California San Diego, San Diego, CA
    J Clin Psychopharmacol 23:389-99. 2003
    ..The continuing development and study of successful interventions to improve medication adherence are necessary to maximize the usefulness of pharmacologic treatment of schizophrenia...
  26. ncbi request reprint Adherence to antipsychotic and nonpsychiatric medications in middle-aged and older patients with psychotic disorders
    Christian R Dolder
    Department of Psychiatry, University of California, San Diego, USA
    Psychosom Med 65:156-62. 2003
    ....
  27. ncbi request reprint Treatment of non-schizophrenic disorders: focus on atypical antipsychotics
    Dilip V Jeste
    University of California, San Diego, San Diego VA Medical Centre 116A 1, 3350 La Jolla Village Drive, San Diego, CA 92161, USA
    J Psychiatr Res 38:73-103. 2004
    ..Due to the frequent clinical use of atypical antipsychotics as adjunctive therapy, well-designed trials of these agents in non-schizophrenic disorders are necessary...
  28. ncbi request reprint Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia
    Todd P Gilmer
    Department of Family and Preventive Medicine, University of California, San Diego, La Jolla 92093 0622, USA
    Am J Psychiatry 161:692-9. 2004
    ..The authors' goal was to evaluate the relationship between adherence to treatment with antipsychotic medication and health expenditures. A secondary objective was to identify risk factors predictive of nonadherence...
  29. ncbi request reprint HIV, psychosis and aging: past, present and future
    Christian R Dolder
    Department of Psychiatry, University of California San Diego, and Pharmacy Service, Veterans Affairs San Diego Healthcare System, USA
    AIDS 18:S35-42. 2004
    ....
  30. ncbi request reprint Brief evaluation of medication influences and beliefs: development and testing of a brief scale for medication adherence
    Christian R Dolder
    Department of Psychiatry, University of California, San Diego, CA, USA
    J Clin Psychopharmacol 24:404-9. 2004
    ..The purpose of this study was to develop and test a brief scale (Brief Evaluation of Medication Influences and Beliefs [BEMIB]) designed to identify patients who are more likely to be nonadherent to their antipsychotic medication...
  31. ncbi request reprint Antihypertensive medication adherence and blood pressure control in patients with psychotic disorders compared to persons without psychiatric illness
    Christian R Dolder
    Department of Psychiatry, University of California, San Diego, USA
    Psychosomatics 46:135-41. 2005
    ..The results highlight the need for clinicians to monitor closely the management of medical comorbidity in patients with schizophrenia and related disorders...
  32. ncbi request reprint Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999-2004
    Todd P Gilmer
    Department of Family and Preventive Medicine, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093 0622, USA
    Psychiatr Serv 58:1007-10. 2007
    ..This study examined trends and costs of second-generation antipsychotic polypharmacy among Medicaid beneficiaries with schizophrenia in San Diego County...
  33. ncbi request reprint Antipsychotic medication adherence: is there a difference between typical and atypical agents?
    Christian R Dolder
    Department of Psychiatry, University of California, San Diego 92161, USA
    Am J Psychiatry 159:103-8. 2002
    ..Pharmacy refill records were used to compare medication adherence in outpatient veterans receiving typical versus atypical antipsychotic medications...